STRIDES PHARMA SCIENCE LIMITED
STAR · ISIN: INE939A01011
Constituent of NIFTY 500 TRI (0.02%), NIFTY SC 250 TRI (0.25%)
Earnings (TTM)
CHART
STRIDES PHARMA SCIENCE LIMITED - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
18.36%
EBITDA Margin (TTM)
66.56
EPS (TTM)
58.87%
EPS Growth (5Y)
20.41%
EPS Growth (10Y)
Technicals
78.7
RSI (14)
1039.47
SMA (50)
981.8
SMA (200)
29.68
ADX (14)
1231
52-Week High
768.65
52-Week Low
32.53%
1Y Return
62.909
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
F&O Sentiment
Nearest expiry: 2022-06-30 · As of 2022-06-30.
0.6046
PCR (OI)
0.8699
PCR (Volume)
325
Max Pain Strike
Corporate Actions
| Ex-Date | Type | Ratio | Details |
|---|---|---|---|
| 2024-12-06 | SPLIT | 0.459614 | implied_from_price |
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns